This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Euan Fordyce: Innovator in Pharmaceutical Research
Introduction
Euan Fordyce is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds.
Latest Patents
Euan Fordyce holds 1 patent for his work on Nicotinamide RIPK1 inhibitors. This patent includes compounds of Formula (I) and pharmaceutically acceptable salts that are useful as RIPK1 inhibitors. The patent also details pharmaceutical compositions comprising these compounds and methods for their use and preparation. Additionally, it provides methods for treating Ulcerative Colitis using a compound of Formula (I).
Career Highlights
Euan Fordyce is currently employed at AbbVie Inc., where he continues to advance his research in the pharmaceutical industry. His work focuses on developing innovative treatments that can significantly impact patient care.
Collaborations
Euan collaborates with talented coworkers, including Sami Osman and James Patrick Stambuli, who contribute to his research efforts and help drive innovation within the company.
Conclusion
Euan Fordyce's contributions to pharmaceutical research, particularly through his patent on Nicotinamide RIPK1 inhibitors, highlight his role as an innovator in the field. His work has the potential to improve treatment options for patients suffering from Ulcerative Colitis.